123: The Beauty of Aging: A Conversation with Elizabeth Barbalich from Antipodes Skincare

What if your menopause journey could be a celebration of your skin's resilience rather than a battle against it? Elizabeth Barbalich, founder and CEO of Antipodes Skincare, shares this refreshing perspective as she joins us to discuss how natural ingredients can address the unique challenges of menopausal skin.From her kitchen table to a global brand sold in over 40 countries, Elizabeth's story embodies the power of female entrepreneurship guided by genuine purpose. She reveals how winning the Entrepreneur of the Year Product Award in New Zealand and Best Emerging Brand in Paris validated her vision, yet she finds the most meaningful moments come from women sharing how her products have genuinely improved their skin health.The conversation delves into why Antipodes created their Jasmine Flower Menopause Facial Cream, a groundbreaking formulation specifically targeting menopausal skin concerns. Elizabeth explains the science behind key ingredients like avananthramides from oat extract that inhibit histamine release, chamomile extracts with neuropeptide properties, and plant-based hyaluronic acid that dramatically improves hydration in dehydrated menopausal skin.What makes this discussion truly valuable is Elizabeth's holistic "inside out, outside in" approach to skincare. She emphasises that no cream alone can solve all skin challenges, advocating for nutritional awareness, reduced inflammatory foods, and increased protein intake alongside targeted skincare. Most refreshingly, she challenges the beauty industry's obsession with lineless skin, instead defining healthy skin as "radiant" regardless of age.Don't forget to follow @SonyaLovell and @AntipodesSkincare on Instagram to enter our special skincare giveaway valued at over $250!Links:Antipodes SkincareAntipodes on InstagramSonya Lovell on InstagramThank you for listening to my show! Join the conversation on Instagram

There are no comments yet.

Please log in to write the first comment.